These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 23307522)

  • 1. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
    Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
    Le F; Arora V; Shah DN; Salazar M; Palmer HR; Garey KW
    Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
    Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
    CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
    Bass SN; Bauer SR; Neuner EA; Lam SW
    J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program.
    Chopra T; Neelakanta A; Dombecki C; Awali RA; Sharma S; Kaye KS; Patel P
    Am J Infect Control; 2015 Apr; 43(4):314-7. PubMed ID: 25838133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection.
    Pettit NN; DePestel DD; Fohl AL; Eyler R; Carver PL
    Pharmacotherapy; 2015 Feb; 35(2):119-26. PubMed ID: 25689243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
    Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA
    Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
    Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
    Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
    Cober ED; Malani PN
    J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.
    Schmiedeskamp M; Harpe S; Polk R; Oinonen M; Pakyz A
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1070-6. PubMed ID: 19803724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
    Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
    Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.